|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5100 CAD | 0.00% |
|
+2.00% | +12.09% |
| 03/06 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 01/06 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | 2.01x | 20.69x | 43.92x | 6.27Cr | |
| -.--% | -.--% | 15.93x | 1.4x | 0.62x | 9.76x | 10.48x | 1.38TCr | |
| -.--% | 1.01% | 20.28x | 2.47x | 0.99x | 15.31x | 15.65x | 676.27Cr | |
| 2.08% | 2.44% | 16.35x | 1.7x | 0.71x | 7.4x | 9.3x | 567.64Cr | |
| 3.45% | 3.81% | 12.46x | 1.88x | 0.79x | 5.68x | 7.44x | 353.51Cr | |
| 3.93% | 4.32% | 16.44x | 7.44x | 1x | 7.48x | 10.39x | 340.76Cr | |
| 5.58% | 6.2% | 14.82x | 4.44x | 1.25x | 7.62x | 14.77x | 331.36Cr | |
| 5.68% | 5.99% | 12.17x | 2.28x | 0.49x | 3.87x | 6.39x | 266.83Cr | |
| 1.67% | 2.02% | 24.65x | 4.31x | 0.7x | 9x | 14.73x | 180.88Cr | |
| 0.01% | -.--% | -87.81x | 2.88x | 0.46x | 17.17x | 100.12x | 152.83Cr | |
| 5.59% | 6.29% | 11.85x | 2.38x | 0.87x | 7.09x | 13.37x | 99Cr | |
| 4.46% | 5.03% | 11.37x | 0.81x | 0.26x | 2.57x | 5.3x | 90Cr | |
| 1.37% | 1.98% | 26.41x | 7.13x | 0.95x | 13.04x | 20.61x | 79Cr | |
| Average | 2.82% | 3.26% | 7.91x | 3.26x | 0.85x | 9.74x | 20.96x | 348.07Cr | |
| Weighted average by Cap. | 1.87% | 2.24% | 12.94x | 2.64x | 0.77x | 9.39x | 14.32x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
